These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 8986209)

  • 1. Decreases in dopamine receptors but not in dopamine transporters in alcoholics.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Hitzemann R; Ding YS; Pappas N; Shea C; Piscani K
    Alcohol Clin Exp Res; 1996 Dec; 20(9):1594-8. PubMed ID: 8986209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.
    Volkow ND; Wang G; Fowler JS; Logan J; Gerasimov M; Maynard L; Ding Y; Gatley SJ; Gifford A; Franceschi D
    J Neurosci; 2001 Jan; 21(2):RC121. PubMed ID: 11160455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography.
    Tiihonen J; Vilkman H; Räsänen P; Ryynänen OP; Hakko H; Bergman J; Hämäläinen T; Laakso A; Haaparanta-Solin M; Solin O; Kuoppamäki M; Syvälahti E; Hietala J
    Mol Psychiatry; 1998 Mar; 3(2):156-61. PubMed ID: 9577840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporters increase in human brain after alcohol withdrawal.
    Laine TP; Ahonen A; Torniainen P; Heikkilä J; Pyhtinen J; Räsänen P; Niemelä O; Hillbom M
    Mol Psychiatry; 1999 Mar; 4(2):189-91, 104-5. PubMed ID: 10208452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics.
    Tiihonen J; Kuikka J; Bergström K; Hakola P; Karhu J; Ryynänen OP; Föhr J
    Nat Med; 1995 Jul; 1(7):654-7. PubMed ID: 7585146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporters decrease with age.
    Volkow ND; Ding YS; Fowler JS; Wang GJ; Logan J; Gatley SJ; Hitzemann R; Smith G; Fields SD; Gur R
    J Nucl Med; 1996 Apr; 37(4):554-9. PubMed ID: 8691238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new PET ligand for the dopamine transporter: studies in the human brain.
    Volkow ND; Ding YS; Fowler JS; Wang GJ; Logan J; Gatley SJ; Schlyer DJ; Pappas N
    J Nucl Med; 1995 Dec; 36(12):2162-8. PubMed ID: 8523098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain.
    Ding YS; Fowler JS; Volkow ND; Logan J; Gatley SJ; Sugano Y
    J Nucl Med; 1995 Dec; 36(12):2298-305. PubMed ID: 8523123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
    Lee CS; Samii A; Sossi V; Ruth TJ; Schulzer M; Holden JE; Wudel J; Pal PK; de la Fuente-Fernandez R; Calne DB; Stoessl AJ
    Ann Neurol; 2000 Apr; 47(4):493-503. PubMed ID: 10762161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
    Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
    J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons.
    Dresel SH; Kung MP; Huang XF; Plössl K; Hou C; Meegalla SK; Patselas G; Mu M; Saffer JR; Kung HF
    J Nucl Med; 1999 Apr; 40(4):660-6. PubMed ID: 10210226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography.
    Tupala E; Hall H; Bergström K; Mantere T; Räsänen P; Särkioja T; Tiihonen J
    Hum Brain Mapp; 2003 Oct; 20(2):91-102. PubMed ID: 14505335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence.
    Hietala J; West C; Syvälahti E; Någren K; Lehikoinen P; Sonninen P; Ruotsalainen U
    Psychopharmacology (Berl); 1994 Nov; 116(3):285-90. PubMed ID: 7892418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T
    J Neurosci; 2000 Sep; 20(18):7067-73. PubMed ID: 10995853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter and D2-receptor density in late-onset alcoholism.
    Repo E; Kuikka JT; Bergström KA; Karhu J; Hiltunen J; Tiihonen J
    Psychopharmacology (Berl); 1999 Dec; 147(3):314-8. PubMed ID: 10639691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
    Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo.
    Wong DF; Harris JC; Naidu S; Yokoi F; Marenco S; Dannals RF; Ravert HT; Yaster M; Evans A; Rousset O; Bryan RN; Gjedde A; Kuhar MJ; Breese GR
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5539-43. PubMed ID: 8643611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo.
    Pohjalainen T; Rinne JO; Någren K; Syvälahti E; Hietala J
    Am J Psychiatry; 1998 Jun; 155(6):768-73. PubMed ID: 9619148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis.
    Hietala J; Någren K; Lehikoinen P; Ruotsalainen U; Syvälahti E
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):210-7. PubMed ID: 10027776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.